Bartell Drugs enters retail clinic arena
SEATTLE — Bartell Drugs will open retail clinics at three of its stores under a partnership with a local health organization, the Seattle-based regional drug store chain said Monday.
Bartell said it would partner with Group Health Cooperative to open clinics at two stores in Seattle and one in the neighboring city of Bellevue, Wash., staffed by nurse practitioners from Group Health. The program is called CareClinic: Group Health at Bartell Drugs, or CareClinic for short, and the initial three clinics will open between January and March 2014.
"The CareClinics reflect our shared vision and commitment to customer service, innovation, improving health and wellness and community collaborations," Bartell chairman and CEO George Bartell said. "We see this as a continuation of Bartell Drugs’ vision to bring new products and services to our customers."
Services will be available to patients aged 2 and older and will provide care for minor illnesses and procedures like cold and flu, sinus infections, allergies, minor injuries, pinkeye, sore throat, headaches, head lice, ringworm, warts, sprains and strains, bronchitis, ear infections, urinary tract infections, diarrhea and intestinal infections.
Decisions of whether to expand the service will be based on how successful the initial three locations are, Bartell said.
Egalet, Shionogi to develop abuse-deterrent opioids
MALVERN, Pa. — Shionogi and Egalet have entered a deal worth up to $425 million for the development of abuse-deterrent opioid painkillers, Egalet said.
The deal centers on the development and potential commercialization of experimental drugs containing the opioid painkiller hydrocodone.
Shionogi will pay Egalet $10 million upfront and purchase $15 million worth of its stock, as well as $300 million or more in milestone payments based on development and approval of products under the agreement. Egalet also is eligible to receive royalties and sales-based milestones of $100 million or more.
Mylan, Elton John AIDS Foundation donate $1 million to end mother-to-child HIV transmission in Nigeria
PITTSBURGH — Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.
The BLC’s goal is to eliminate mother-to-child transmission of HIV in Nigeria, which is home to 3.4 million people living with the disease, and about 60,000 children were newly infected with it in 2012 alone, the highest rate in the world, according to UNAIDS. In Nigeria, mother-to-child transmission of HIV has remained at 30% despite its virtual elimination in other countries, such as the United States and Botswana.
"Mylan is proud to commemorate World AIDS Day by announcing this important partnership with EJAF and BLC to reach more HIV-positive pregnant women in Nigeria," Mylan CEO Heather Bresch said, adding that 40% of people receiving treatment for HIV in developing countries rely on a Mylan product. "Ending transmission of HIV from mother to child is an important step in ending AIDS."